Even if you meet the diagnostic criteria weve discussed, you would not be indicated for a weight loss peptide if you are: Pregnant Animal studies show that the offspring of pregnant subjects exposed to GLP-1 RAs may develop skeletal abnormalities, have a low birth weight, and exhibit substandard growth.23 Although no congenital malformations have been widely identified in humans, people who are pregnant or planning to become pregnant are advised to forgo or end their GLP-1 RA treatment
Who makes the JDC1 and where does it sit in the GLP range
However, given their enormous popularity, equally effective oral formulations of these drugs are likely to come to market over the next few years
** What is Oral Semaglutide Oral semaglutide is a prescription medication for type 2 diabetes, and may also be prescribed for weight loss
Originally developed for type 2 diabetes, they reduce A1C levels, support insulin release, and help the body use glucose more efficiently